The New York Times reports a breakthrough for Alzheimer’s disease as the FDA announced it will have looser rules on approving drugs for treatment. In the past, pharmaceutical companies had to show that drugs improved “daily, real-world functioning,” but now “Drugs in clinical trial would qualify for...